Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 5.73M | - |
| Gross profit | 973K | - |
| Net profit | -1.54M | - |
| EBITDA | -1.24M | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €3.09M |
Number of shares | 35.54M |
52-week high/low | €0.21 - €0.087 |
| Dividends | No |
Beta | 0.30 |
P/E ratio | -1.31 |
PEG ratio | -0.02 |
P/B ratio | 0.13 |
P/S ratio | 0.25 |
Company profile
Spineway SA engages in the design, manufacture, and marketing of implants and surgical instruments for treating disorder of spinal column. The company offers ayers rock, an anterior cervical interbody fusion cage; blue mountain, an anterior cervical interbody fusion plate; mont blanc, a posterior thoracolumbar pedicle screws; mont blanc baby, a pediatric growing rod system; mont blanc 3d+, a coplanar alignment system; kili, an anterior lumbar interbody fusion cage; twin peaks plif bullet shaped posterior lumbar interbody fusion cages; twin peaks olif graft vascularization interbody fusion cages; twin peaks tlif transforaminal lumbar interbody fusion cages; and mont blanc mis, a mini-invasive thoracolumbar system. It also provides sonora, a biomaterial for bone regeneration. In addition, the company exports its products. Spineway SA was incorporated in 2005 and is headquartered in Ecully, France.
| Name | SPINEWAY EO 4,- |
| CEO | Stéphane Le Roux |
| Headquarters | Ecully,
ar France |
| Website | |
| IPO | 02/13/2013 |
| Employees | 43 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Euronext | ALSPW.PA |
Frankfurt | 37S.F |
Paris | ALSPW.PA |
München | 37S.MU |